Aclidinium bromide / formoterol fumarate dihydrate (Brimica® Genuair®)
Brimica® Genuair® is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with COPD.
Rapid Review
| Commenced | Completed | Outcome |
| 05/01/2015 | 09/02/2015 | Full Pharmacoeconomic Evaluation Recommended at submitted price. |
The company has not submitted a HTA dossier to the NCPE therefore the cost effectiveness of the technology could not be proven.